Literature DB >> 12209800

Fractional precipitation of plasmid DNA from lysate by CTAB.

Russel J Lander1, Michael A Winters, Francis J Meacle, Barry C Buckland, Ann L Lee.   

Abstract

Preparative-scale purification of plasmid DNA has been attempted by diverse methods, including precipitation with solvents, salts, and detergents and chromatography with ion-exchange, reversed-phase, and size-exclusion columns. Chromatographic methods such as hydrophobic interaction chromatography (HIC), reversed phase chromatography (RPC), and size exclusion chromatography (SEC) are the only effective means of eliminating the closely related relaxed and denatured forms of plasmid as well as endotoxin to acceptable levels. However, the anticipated costs of manufacturing-scale chromatography are high due to (a) large projected volumes of the high-dosage therapeutic molecule and (b) restricted loading of the large plasmid molecule in the pores of expensive resins. As an alternative to chromatography, we show herein that precipitation with the cationic detergent, cetyltrimethylammonium bromide (CTAB), is effective for selective precipitation of plasmid DNA from proteins, RNA, and endotoxin. Moreover, CTAB affords novel selectivity by removal of host genomic DNA and even the more closely related relaxed and denatured forms of plasmid as earlier, separate fractions. Finally, plasmid that has been precipitated by CTAB can be purified by selectively dissolving under conditions of controlled salt concentration. The selectivity mechanism is most likely based upon conformational differences among the several forms of DNA. As such, CTAB precipitation provides an ideal nonchromatographic capture step for the manufacture of plasmid DNA. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209800     DOI: 10.1002/bit.10335

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  4 in total

1.  An affordable plasmid miniprep suitable for proficient microinjection in Caenorhabditis elegans.

Authors:  Hyun-Min Kim; Sisi Tian; Shouyue Wang
Journal:  3 Biotech       Date:  2020-07-22       Impact factor: 2.406

2.  Intramammary expression and therapeutic effect of a human lysozyme-expressing vector for treating bovine mastitis.

Authors:  Huai-chang Sun; Fang-ming Xue; Ke Qian; Hao-xia Fang; Hua-lei Qiu; Xin-yu Zhang; Zhao-hua Yin
Journal:  J Zhejiang Univ Sci B       Date:  2006-04       Impact factor: 3.066

3.  Aromatic Polyketides from a Symbiotic Strain Aspergillus fumigatus D and Characterization of Their Biosynthetic Gene D8.t287.

Authors:  Yi Hua; Rui Pan; Xuelian Bai; Bin Wei; Jianwei Chen; Hong Wang; Huawei Zhang
Journal:  Mar Drugs       Date:  2020-06-20       Impact factor: 5.118

Review 4.  Bioprocess engineering issues that would be faced in producing a DNA vaccine at up to 100 m3 fermentation scale for an influenza pandemic.

Authors:  Mike Hoare; M Susana Levy; Daniel G Bracewell; Steven D Doig; Simyee Kong; Nigel Titchener-Hooker; John M Ward; Peter Dunnill
Journal:  Biotechnol Prog       Date:  2005 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.